Skip to main content

Peer Review reports

From: Comparison of renin–angiotensin–aldosterone system inhibitors with other antihypertensives in association with coronavirus disease-19 clinical outcomes

Original Submission
28 Sep 2020 Submitted Original manuscript
11 Nov 2020 Reviewed Reviewer Report
24 Dec 2020 Reviewed Reviewer Report - Belaynew Wasie Taye
21 Jan 2021 Author responded Author comments - Yihienew Mequanint Bezabih
Resubmission - Version 2
21 Jan 2021 Submitted Manuscript version 2
25 Mar 2021 Reviewed Reviewer Report - Sumit Ghosh
27 Mar 2021 Reviewed Reviewer Report
3 Apr 2021 Author responded Author comments - Yihienew Mequanint Bezabih
Resubmission - Version 3
3 Apr 2021 Submitted Manuscript version 3
16 Apr 2021 Author responded Author comments - Yihienew Mequanint Bezabih
Resubmission - Version 4
16 Apr 2021 Submitted Manuscript version 4
Publishing
20 Apr 2021 Editorially accepted
5 Jun 2021 Article published 10.1186/s12879-021-06088-6

You can find further information about peer review here.

Back to article page